Headache Sciences Inc.
Headache Sciences offers an AI-based diagnostic tool that provides objective migraine diagnosis and monitoring in clinical settings. The platform uses machine learning on EEG data as a Software as a Medical Device (SaMD) to deliver objective diagnostic tests for neurologists and headache specialists. It analyzes brain activity biomarkers between migraine attacks with signal processing and AI-driven algorithms to enable faster diagnosis and ongoing treatment monitoring. The company targets neurology clinics and aims to collaborate with pharmaceutical developers for companion diagnostics and drug development, positioning itself to scale in the migraine market.
Headache Sciences Inc.
Headache Sciences offers an AI-based diagnostic tool that provides objective migraine diagnosis and monitoring in clinical settings. The platform uses machine learning on EEG data as a Software as a Medical Device (SaMD) to deliver objective diagnostic tests for neurologists and headache specialists. It analyzes brain activity biomarkers between migraine attacks with signal processing and AI-driven algorithms to enable faster diagnosis and ongoing treatment monitoring. The company targets neurology clinics and aims to collaborate with pharmaceutical developers for companion diagnostics and drug development, positioning itself to scale in the migraine market.